Genomic Health Inc. (GHDX) Fell -11.58% or -7.58 To Price $57.88 On Wednesday


Genomic Health Inc. (GHDX) fell -11.58% or -7.58 to $57.88. It is about 1.76 million shares traded, which is 341.64% compare to the average total volume 515386. The market cap of GHDX is $2.15 billion. The year to date change is -6.37%. The 52 week price range is from $35.42 to $92.18. Price of GHDX have changed 2.54% during last week. It have changed -3.57% over last month, -15.79% over last 3 months, -27.41% over last 6 months and 80.98% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GHDX is 69.82. It is 20.63% above current price. The 200-day Moving Averages for GHDX is 68.18. It is 17.80% above current price. The 52-week High is 92.18. It is 59.26% from the current price. The 52-week Low is 35.42. It is -38.80% from current price.

There are some statistics of GHDX. It is has market cap $2.15 billion. The share outstanding is 37.07 million. The average volume is 515386. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GHDX is 11.40%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GHDX is 9.23%.


Tags:

Share this post